Therapeutic effect of urethral sphincter onabotulinumtoxinA injection for urethral sphincter hyperactivity.
Hann-Chorng KuoSheng-Fu ChenJia-Fong JhangHann-Chorng KuoPublished in: Neurourology and urodynamics (2018)
Subjective improvement was reported in 61.1% of patients with voiding dysfunction due to urethral sphincter hyperactivity after onabotulinumtoxinA urethral sphincter injection. An open bladder neck during voiding at baseline predicts a successful outcome.